Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 1 Lymphopenia 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1 COVID-19 1

Interventions

efineptakin alfa 1 Sodium Chloride 1 Interleukin-7 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphopenia × Interleukin-7 × Clear all

NCT04426201 2024-04-11

ILIAD-7-US-O

Revimmune

Phase 2 Terminated

COVID-19, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡